Utility of MRI in diagnosis of molecular subtypes of breast cancer

Background: Breast cancer is a collection of diseases defined by distinct pathological (e.g., ductal, lobular, mucinous) and molecular characteristics (e.g., ER and PR, HER2 amplification, and more recently transcriptome-based classifications such as luminal and basal cancers). Molecular subtyping i...

Full description

Bibliographic Details
Main Authors: Ebtsam Ahmed Mohammed*, Mohamed Tharwat Mahmoud Solyman, Nagham Nabil Omar, Nahla Mohamed Ali Hasan
Format: Article
Language:English
Published: South Valley University, Faculty of Medicine 2022-01-01
Series:SVU - International Journal of Medical Sciences
Subjects:
Online Access:https://svuijm.journals.ekb.eg/article_199523.html
_version_ 1818049754209189888
author Ebtsam Ahmed Mohammed*
Mohamed Tharwat Mahmoud Solyman
Nagham Nabil Omar
Nahla Mohamed Ali Hasan
author_facet Ebtsam Ahmed Mohammed*
Mohamed Tharwat Mahmoud Solyman
Nagham Nabil Omar
Nahla Mohamed Ali Hasan
author_sort Ebtsam Ahmed Mohammed*
collection DOAJ
description Background: Breast cancer is a collection of diseases defined by distinct pathological (e.g., ductal, lobular, mucinous) and molecular characteristics (e.g., ER and PR, HER2 amplification, and more recently transcriptome-based classifications such as luminal and basal cancers). Molecular subtyping is beneficial for the diagnosis and individualized treatment of breast cancer.MRI is a supplemental technique to mammography and ultrasonography for the evaluation of breast lesions and to predict molecular subtypes of breast cancer. Studies have highlighted the value of DCE-MRI in reflecting the anatomic and functional properties of tumors and facilitating treatment. Objectives: The aim of this work was to assess the utility of MRI as an accurate method for detection of molecular subtypes of breast cancer. Patients and Methods: a retrospective clinical study of 2-years enrollment duration. The study was conducted at Radiology Department, Assuit University Hospitals on 50 lesions, patient age ranging from 23 to 66 years old with mean age was (46.9 ± SD) years. MR imaging studies were performed using a 1.5 T Magnetom Vision scanner with dedicated bilateral phased-array breast coil (Siemens, Erlangen, Germany). MRI sequences were 1. Axial T1WI. 2. Axial T2WI. 3. Axial STIR. 4. Axial DWI and ADC. 5. DCE-MRI. Results: The study included 50 lesions; 21 lesions were Luminal A, 15 lesions were Luminal B, 10 lesions were HER2+, and 4 lesions were TN. Histopathology 39 lesions were IDC-NOS, 1 lesion was IDC (medullary type), 7 lesions were mixed pathology IDC + DCIS, and 3 lesions were ILC. As regard the correlation between the histopathological type and grade, both were specific in differentiation between the molecular subtypes. According to the MRI findings it was found that T2 Intratumoral signal intensity, STIR, and the margin of the lesion were highly specific in differentiation, both L.N status and number were found that they were highly specific in differentiation (p <0.001), while size of the lesion, T1WI signal, ADC values were found that they were non-specific in differentiation between the molecular subtypes of breast cancer. Conclusion: Breast MRI may help in assessing different molecular subtypes of breast cancer.
first_indexed 2024-12-10T10:42:36Z
format Article
id doaj.art-fd0d31505b3b4b658f7ea914d9e6ef9f
institution Directory Open Access Journal
issn 2735-427X
2636-3402
language English
last_indexed 2024-12-10T10:42:36Z
publishDate 2022-01-01
publisher South Valley University, Faculty of Medicine
record_format Article
series SVU - International Journal of Medical Sciences
spelling doaj.art-fd0d31505b3b4b658f7ea914d9e6ef9f2022-12-22T01:52:15ZengSouth Valley University, Faculty of MedicineSVU - International Journal of Medical Sciences2735-427X2636-34022022-01-01513447https://dx.doi.org/10.21608/svuijm.2021.99249.1226Utility of MRI in diagnosis of molecular subtypes of breast cancerEbtsam Ahmed Mohammed*0Mohamed Tharwat Mahmoud Solyman1 Nagham Nabil Omar2Nahla Mohamed Ali Hasan3Department of Radio-Diagnosis, Faculty of Medicine, Sohag University, Sohag, Egypt.Department of Radio-Diagnosis, Faculty of Medicine, Sohag University, Sohag, Egypt.Department of Radio-Diagnosis, Faculty of Medicine, Assiut University, Assiut, Egypt.Department of Radio-Diagnosis, Faculty of Medicine, Sohag University, Sohag, Egypt.Background: Breast cancer is a collection of diseases defined by distinct pathological (e.g., ductal, lobular, mucinous) and molecular characteristics (e.g., ER and PR, HER2 amplification, and more recently transcriptome-based classifications such as luminal and basal cancers). Molecular subtyping is beneficial for the diagnosis and individualized treatment of breast cancer.MRI is a supplemental technique to mammography and ultrasonography for the evaluation of breast lesions and to predict molecular subtypes of breast cancer. Studies have highlighted the value of DCE-MRI in reflecting the anatomic and functional properties of tumors and facilitating treatment. Objectives: The aim of this work was to assess the utility of MRI as an accurate method for detection of molecular subtypes of breast cancer. Patients and Methods: a retrospective clinical study of 2-years enrollment duration. The study was conducted at Radiology Department, Assuit University Hospitals on 50 lesions, patient age ranging from 23 to 66 years old with mean age was (46.9 ± SD) years. MR imaging studies were performed using a 1.5 T Magnetom Vision scanner with dedicated bilateral phased-array breast coil (Siemens, Erlangen, Germany). MRI sequences were 1. Axial T1WI. 2. Axial T2WI. 3. Axial STIR. 4. Axial DWI and ADC. 5. DCE-MRI. Results: The study included 50 lesions; 21 lesions were Luminal A, 15 lesions were Luminal B, 10 lesions were HER2+, and 4 lesions were TN. Histopathology 39 lesions were IDC-NOS, 1 lesion was IDC (medullary type), 7 lesions were mixed pathology IDC + DCIS, and 3 lesions were ILC. As regard the correlation between the histopathological type and grade, both were specific in differentiation between the molecular subtypes. According to the MRI findings it was found that T2 Intratumoral signal intensity, STIR, and the margin of the lesion were highly specific in differentiation, both L.N status and number were found that they were highly specific in differentiation (p <0.001), while size of the lesion, T1WI signal, ADC values were found that they were non-specific in differentiation between the molecular subtypes of breast cancer. Conclusion: Breast MRI may help in assessing different molecular subtypes of breast cancer.https://svuijm.journals.ekb.eg/article_199523.htmlmolecular subtype; luminal a; luminal b; her2+; triple-negative; mri; adc; dce-mri
spellingShingle Ebtsam Ahmed Mohammed*
Mohamed Tharwat Mahmoud Solyman
Nagham Nabil Omar
Nahla Mohamed Ali Hasan
Utility of MRI in diagnosis of molecular subtypes of breast cancer
SVU - International Journal of Medical Sciences
molecular subtype; luminal a; luminal b; her2+; triple-negative; mri; adc; dce-mri
title Utility of MRI in diagnosis of molecular subtypes of breast cancer
title_full Utility of MRI in diagnosis of molecular subtypes of breast cancer
title_fullStr Utility of MRI in diagnosis of molecular subtypes of breast cancer
title_full_unstemmed Utility of MRI in diagnosis of molecular subtypes of breast cancer
title_short Utility of MRI in diagnosis of molecular subtypes of breast cancer
title_sort utility of mri in diagnosis of molecular subtypes of breast cancer
topic molecular subtype; luminal a; luminal b; her2+; triple-negative; mri; adc; dce-mri
url https://svuijm.journals.ekb.eg/article_199523.html
work_keys_str_mv AT ebtsamahmedmohammed utilityofmriindiagnosisofmolecularsubtypesofbreastcancer
AT mohamedtharwatmahmoudsolyman utilityofmriindiagnosisofmolecularsubtypesofbreastcancer
AT naghamnabilomar utilityofmriindiagnosisofmolecularsubtypesofbreastcancer
AT nahlamohamedalihasan utilityofmriindiagnosisofmolecularsubtypesofbreastcancer